• "The show works because it's for the common man, " says Crorepati producer Anita Kaul Basu.

    CNN: The Hottest TV Show

  • Dr. Kaul, based at Cedars-Sinai Medical Center in Los Angeles, says the rat issue didn't figure significantly in his vote.

    WSJ: FDA Set to Decide Obesity Drug Lorcaserin's Fate

  • Dr. Kaul is an internationally recognized heart researcher renowned for developing microbubble-based myocardial contrast echocardiography for the early detection of coronary heart disease.

    FORBES: Move up http://i.forbesimg.com t Move down

  • Samir Kaul, a founding general partner at Khosla Ventures, one of the premier cleantech venture firms, says investors likely will have done their homework out of necessity.

    FORBES: Seeing Green In Cleantech

  • Starr and Kaul will co-lead the OHSU Knight Cardiovascular Institute.

    FORBES: Move up http://i.forbesimg.com t Move down

  • India's airlines struggle to make a profit, mostly because of high costs of imported jet fuel, said Kapil Kaul, an analyst at the India office of Sydney-based CAPA-Centre for Aviation.

    WSJ: India Moving to Reduce Airport Fees

  • "It is a distortion of the scientific process when a company releases data only under media duress or fear of congressional inquiry, " says Sanjay Kaul of Cedars Sinai Medical Center.

    FORBES: Magazine Article

  • According to Kapil Kaul, chief executive, Centre for Asia Pacific Aviation India, the number of airline passengers is expected to grow nearly four-fold from 123 million to 450 million by 2020.

    FORBES: Indian high flier's mega deal

  • Another investor wrote to Dr. Kaul, the panelist, politely suggesting that, "to hear the scuttlebutt going around, " the panelists incorrectly assumed a risk to humans after some rats on lorcaserin developed tumors.

    WSJ: FDA Set to Decide Obesity Drug Lorcaserin's Fate

  • "It's a good thing everybody is allowed to have their say, but the FDA has to do its job, " said heart-disease expert Sanjay Kaul, who served as an FDA adviser and voted against lorcaserin.

    WSJ: FDA Set to Decide Obesity Drug Lorcaserin's Fate

  • The advisory committee meeting will undoubtedly feature some heated discussion, especially since both Steve Nissen, the noted industry skeptic, and Sanjay Kaul, a tough critic of clinical trials, will be members of the panel.

    FORBES: FDA Reviewers Recommend Complete Response Letter for Rivaroxaban (Xarelto)

  • But only a quarter of patients take it when prescribed, says Sanjay Kaul of Cedars-Sinai Medical Center, because of an annoying but relatively harmless side effect: Niacin makes people turn beet red and feel unpleasantly hot.

    FORBES: Merck's Good Cholesterol Battle

  • "AirAsia will initially start on a low-scale but once they scale up their operations, I would expect them to be a formidable competitor in India, " said Kapil Kaul, the South Asia chief executive at aviation consultancy CAPA-Centre for Aviation.

    WSJ: India Approves AirAsia's Airline Proposal

  • Sanjay Kaul, a cardiologist at Cedars Sinai Hospital in L.A. who has been an FDA consultant, says the FDA should now require all cholesterol medicines to either do a big study showing they prevent heart problems before approval or only grant conditional approval and then demand the big study.

    FORBES: Why Merck's Niacin Failure Will Scare Drug Researchers

  • Fund manager Rajiv Kaul has focused on a handful of relatively new companies, including high-speed router maker Juniper Net (nasdaq: JUNI) at 8.98% of holdings, semiconductor manufacturer JDS Uniphase (nasdaq: JDSU - news - people) at 6.09% and optical networking vendor Sycamore Networks (nasdaq: SCMR - news - people) at 3.14%.

    FORBES: Telecom Funds: Balancing on the Wires

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定